Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

Singapore’s biopharmaceutical industry is expected to benefit after a surge in drug production as companies anticipate changes in U.S. trade policy.

Leave a Reply

Your email address will not be published.

Previous Story

Japanese Prime Minister Sanae Takaichi to dissolve Lower House for Feb. 8 snap election

Next Story

Scrapping direct regional elections in Indonesia shifts power to elites, analysts warn

Previous Story

Japanese Prime Minister Sanae Takaichi to dissolve Lower House for Feb. 8 snap election

Next Story

Scrapping direct regional elections in Indonesia shifts power to elites, analysts warn

Don't Miss